Ensysce Biosciences

Ensysce Biosciences Gross Margin

The Gross Margin of Ensysce Biosciences (ENSC) as of Nov 21, 2026 is -104.81 %. In the previous year, Gross Margin was -38.57 % — a change of 171.75% (lower).

Gross Margin

-104.81 %

YoY

171.75%

Last updated:

Gross Margin of Ensysce Biosciences is 2025 -104.81 % . Gross Margin of Ensysce Biosciences was 2024 -38.57 % . It decreases by 171.75% lower compared to the previous year.

For Ensysce Biosciences, the gross margin of -104.8% is down versus 100.0% a few years ago.

The Ensysce Biosciences Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
-188.70 USD
Jan 1, 2020
99.99 USD
Jan 1, 2021
100.00 USD
Jan 1, 2022
-686.08 USD
Jan 1, 2023
-240.12 USD
Jan 1, 2024
-38.57 USD
Jan 1, 2025
-104.81 USD
The Ensysce Biosciences Gross Margin history
YEARGross MarginYoY
-104.81 %+171.75%
-38.57 %-83.94%
-240.12 %-65.00%
-686.08 %-786.11%
100.00 %+0.00%
99.99 %-152.99%
-188.70 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ensysce Biosciences Stock analysis

What does Ensysce Biosciences do? Ensysce Biosciences Inc, based in La Jolla, California, is a clinical-stage biopharmaceutical company operating in the Health Care sector. It develops innovative solutions for severe pain relief with reduced risk of opioid misuse, abuse, and overdose. The company utilizes proprietary technology platforms, including TAAP for abuse-resistant opioids and MPAR for overdose protection, to create safer prescription drugs. With 7 employees, it focuses on advancing its pipeline of novel drug platforms to address critical challenges in pain management. Ensysce Biosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ensysce Biosciences stock

Gross Margin of Ensysce Biosciences is -104.81 % in 2025.

Gross Margin of Ensysce Biosciences changed from -38.57 % to -104.81 %, representing a 171.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Ensysce Biosciences since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Ensysce Biosciences with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Ensysce Biosciences

All Key Metrics — Ensysce Biosciences